Sarepta Therapeutics, Inc 10-Q for FY2025 Q3
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2025-11-06
For: 2025-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on November 6, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $399.36M
- down 14.5% from $467.17M a year earlier
- Net loss
- $179.95M
- compared with net income of $33.61M a year earlier
- Diluted EPS
- -$1.80
- compared with $0.34 a year earlier